| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Traumatology,*
University of
Freiburg, Freiburg, Germany; Sumitomo Pharmaceuticals Research
Center,
Osaka, Japan; and Department of
Pathology,
University of Michigan, Ann
Arbor, Michigan
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
. In
contrast, in the cobra venom factor model, upregulation
of P-selectin, which is C5a dependent, was also
dimethyl sulfoxide sensitive but neutrophil independent.
Different mechanisms that may explain why upregulation of lung
vascular P-selectin is either transient or sustained are
discussed.
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
and interleukin-1). In turn, these
cytokines are required for upregulation of lung vascular intercellular
adhesion molecule (ICAM)-1 and E-selectin and for the subsequent
recruitment of neutrophils.1-3
The process of neutrophil
recruitment also involves L-selectin, ICAM-1, and the ß2 integrins
CD11a/CD18 (leukotactic factor activity) and CD11b/CD18
(Mac-1).2,4-7
Based on the use of selectin-IgG chimeric
molecules, it has been suggested that P-selectin is not required for
neutrophil recruitment in this inflammatory model.8
This
contrasts with lung injury induced by intravenous infusion of cobra
venom factor (CVF) in which P-selectin plays an important and early
role, based on findings with a cross-reactive anti-human P-selectin
monoclonal antibody and the use of human P-selectin-IgG.8,9
In the CVF inflammatory model, upregulation of lung vascular P-selectin
is transient, dependent on availability of C5a, and platelet
independent.10
Mutant mice lacking the ability to express
P-selectin display a series of defective inflammatory responses,
including inflammatory peritoneal exudates and delayed-type
hypersensitivity reactions,11
although other studies
suggest that the full development of peritoneal inflammatory exudates
requires both L- and P-selectin.12 In the following studies, we sought to explore the expression and role of P-selectin in inflammatory injury after intrapulmonary deposition of IgG immune complexes or CVF-induced systemic complement activation in rats using a monoclonal antibody to rat P-selectin. The data to be presented reveal that lung vascular upregulation of P-selectin in the immune complex model occurs early and is persistent over many hours. This upregulation is complement and neutrophil dependent and can be suppressed in the presence of the antioxidant dimethyl sulfoxide (DMSO). P-selectin blockade suppresses neutrophil recruitment and full development of injury in this model. The pattern of persistent expression of P-selectin upregulation is strikingly different from that found in the model of lung injury after systemic activation of complement. These data suggest that there may be different pathways that bring about in vivo upregulation of lung vascular P-selectin.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Male Long Evans (specific pathogen-free) rats (275 to 300 g, Charles River Breeding Laboratories, Inc., Portage, MI) were used in all studies. Intraperitoneal injections of ketamine (10 to 15 mg/100 g body weight) were given for sedation and anesthesia. Polyclonal rabbit IgG containing 2.5 mg of anti-bovine serum albumin purchased from Organon Teknika Corp. (West Chester, PA) was instilled (in 300 µl phosphate-buffered, pH 7.4, saline (PBS)) into the lungs via a tracheal cannula. Control animals received 2.5 mg of nonspecific rabbit IgG intratracheally. Ten mg of bovine serum albumin (together with trace amounts of 125I-labeled bovine serum albumin) was injected intravenously (in 0.5 ml of PBS) immediately after the intratracheal injections. The rats were sacrificed 4 hours later, unless otherwise indicated, and the permeability index was calculated as described elsewhere.2
CVF Model of Acute Lung Injury
Animals were anesthetized as described above. CVF was isolated from lyophilized Naja kaouthia venom (Sigma Chemical Co., St. Louis, MO) by ion exchange and gel filtration chromatography.13 CVF (3.5 units) diluted in a final volume of 0.3 ml of PBS was given in a bolus intravenous injection. Control animals received PBS only. Sacrifice of rats occurred at 30 minutes after the injections.
Measurement of Lung Vascular P-Selectin
As a marker for the expression of P-selectin, 5 µl (5 µg) of 125I-labeled mouse monoclonal antibody (IgG1) to human P-selectin (PB1.3) (Cytel Corp., San Diego, CA) or an irrelevant subclass-matched murine Ig, 125I-labeled MOPC-21, was injected intravenously 15 minutes before sacrifice. This antibody was used to make comparisons with previously published data dealing with upregulation of lung vascular P-selectin after systemic activation of complement.10 At the time of sacrifice, 1.0 ml of blood was drawn from the posterior vena cava, and the lung vasculature was flushed through the pulmonary artery with 10 ml of PBS. The ratio of radioactivity remaining in the lung to that contained in the blood sample represented fixation of monoclonal antibody to rat lung (binding index). 125I-labeled MOPC-21 served as an indicator of nonspecific fixation (or leakage) of antibody to (from) the lung vasculature. Sacrifice of rats in the CVF model of lung injury occurred at 30 minutes after CVF injection (unless otherwise indicated), whereas in the IgG immune complex model, rats were killed at various time points (up to 8 hours) after immune complex deposition.
Immunostaining for Lung Vascular P-Selectin
Frozen sections of lung tissue were prepared as described previously.1,2 Samples were fixed in methanol at -20°C for 10 minutes before immunostaining. Anti-P-selectin mouse monoclonal antibody (ARP2-4) (dilution 1/250 in PBS) was incubated at room temperature in a humidified chamber for 60 minutes.14,15 Slides were washed in PBS and incubated for 60 minutes with peroxidase-conjugated goat anti-mouse IgG (Sigma) diluted 1/10,000 in PBS. P-selectin was visualized using diaminobenzidine substrate (Kirkegaard and Perry Inc., Gaithersburg, MD), and the tissues were counterstained with hematoxylin. Samples were examined by light microscopy.
Effects of DMSO or Neutrophil Depletion on Upregulation of Lung Vascular P-Selectin
To assess the extent to which upregulation of lung vascular P-selectin may be related to requirement for oxidants, 1.0 ml of DMSO (Burdick & Jackson Laboratories, Inc., Muskegon, MI) was injected intraperitoneally 10 minutes before initiation of lung inflammatory reactions. This protocol has been shown to be protective against oxidant-induced lung injury.16,17 The protective effects of DMSO under such conditions appear to be related to its ability to function as a scavenger of the hydroxyl radical,18-21 which has been incriminated as a toxic oxygen metabolite involved in neutrophil-mediated lung injury as well as in neutrophil-mediated injury in vitro of endothelial cells.22-25 Neutrophil depletion was induced by the intraperitoneal injection of 0.5 ml of rabbit serum to rat neutrophils (Accurate Chemical & Scientific Corp., Westbury, NY) 12 hours before the onset of injury. Both models of lung injury are known to be neutrophil dependent.16,17,26 The neutrophil counts in normal rat blood (2.21 x 103/mm3) dropped by 92% in animals treated with this antiserum, whereas there were no significant changes in counts of blood mononuclear cells and platelets (data not shown).
Requirements for Complement, C5a, and TNF- in Upregulation of
Lung Vascular P-Selectin
The requirements for complement, C5a, and TNF- in upregulation
of lung vascular P-selectin were determined. Complement depletion was
induced by repeated intraperitoneal injections of CVF. Twenty units of
CVF were given 36, 24, and 12 hours before the onset of
injury.9,10
The requirements for TNF- and C5a were
determined by intratracheal instillation (at the onset of injury) of
400 µg of rabbit IgG reactive with TNF- or C5a.27
Western Blot Analysis of Homogenates from Whole Lung
The IgG immune complex model was used as described above. At the times indicated, the lungs were flushed with 10 ml of PBS through the pulmonary artery, surgically dissected, and immediately frozen in liquid nitrogen. Mechanical homogenization at 5°C was performed using a homogenization buffer containing 0.6% Nonidet P-40, 10 mmol/L HEPES, pH 7.9, 150 mmol/L NaCl, 1 mmol/L ethylenediaminetetraacetic acid, and 0.5 mmol/L phenylmethylsulfonylfluoride (Sigma). The tissue homogenates were sonicated for 30 seconds and centrifuged at 2500 rpm for 30 minutes at 4°C. The resulting supernatant fluids were used for analysis. To load equal amounts of protein onto the gel, a bicinchoninic protein assay (Pierce Co., Rockford, IL) was performed. The samples were analyzed on a 7.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis (National Diagnostics, Inc., Atlanta, GA) together with a high molecular weight standard (Life Technologies, Inc., Gaithersburg, MD). The gel was transferred on Westran polyvinylidene difluoride membrane (Schleicher & Schuell Co., Keene, NH) using protocols described elsewhere (R & D Systems, Inc., Minneapolis, MN). The blot was blocked overnight in 5% bovine powdered milk at 4°C. The primary reagent, monoclonal antibody to rat P-selectin (described below), was added at a 1:1000 dilution in 1% milk and incubated for 1 hour at room temperature. The blot was washed three times for 5 minutes each in Tris-buffered saline containing 0.5% polyoxyethylene sorbitan monolaurate (Tween 20) (Sigma). Immunostaining was performed using rabbit anti-mouse IgG horseradish peroxidase conjugate (Amersham, Inc., Arlington Heights, IL) at a 1:20,000 dilution in 1% milk. After a 1-hour incubation, the blot was washed three times for 5 minutes each in Tris-buffered saline containing 0.5% Tween 20. The blot was put on plastic foil and covered with enhanced chemiluminescence (Amersham). Western blotting detection reagents were applied for 1 minute. The fluids were poured off the membrane, and the blot was wrapped in plastic foil and placed into a film cassette. Hyperfilm (Amersham) was exposed overnight.
Northern Blot Analysis of mRNA for P-Selectin and TNF-
Acute lung injury was induced in rats by IgG immune complex
deposition as described above. Rats were sacrificed at the times
indicated after induction of injury. Total RNA was isolated from lungs
using acid-guanidium-phenol-chloroform. Fifteen µg of RNA were
loaded per lane and subjected to electrophoretic separation on a 1%
agarose/formaldehyde gel. The RNA was then transferred onto a
GeneScreen nylon membrane (NEN, Inc., Wilmington, DE) by the capillary
method. Before hybridization, the transferred RNA was cross-linked to
the membrane by ultraviolet-light irradiation. Hybridization was
performed overnight at 42°C in a buffer containing 50% formamide,
5x standard saline sulfate (750 nmol/L NaCl and 75 mmol/L sodium
citrate), 1% sodium dodecyl sulfate, 2x Denhardt's solution, and 0.1
mg/ml denatured salmon sperm DNA. 32P-labeled cDNA probes
for rat P-selectin and mouse TNF- as well as human ß-actin were
then applied. The cDNA probe for rat P-selectin is described in recent
reports.14,15
After the hybridization, the filter was
washed twice in 2x standard saline sulfate at room temperature for 10
minutes followed by addition of 2x standard saline sulfate and 0.1%
sodium dodecyl sulfate at 65°C for 30 minutes. Then the filter was
exposed to X-ray film.
Lung Neutrophil Content
The neutrophil content of lung was measured as neutrophil counts in bronchoalveolar lavage (BAL) fluids. After sacrifice, 5 ml of sterile PBS was instilled into the lungs via an intratracheal cannula. The liquid was aspirated, and the procedure was repeated twice. BAL fluids were centrifuged for 15 minutes at 1500 rpm. NaCl (0.9%) was added to the samples to reproduce the initial volumes of the BAL fluids. Ten µl of each sample were analyzed using conventional microcytometry.
Effects on IgG Immune Complex-Induced Lung Injury by Anti-P-Selectin
Together with the bovine serum albumin, 400 µg of mouse monoclonal antibody against rat-P-selectin (ARP2-4) (Sumitomo Pharmaceuticals, Inc., Osaka, Japan)14,15 were injected intravenously at the indicated time points. Companion positive control animals received 400 µg of MOPC-21 instead of ARP2-4.
Statistical analysis
All values were expressed as mean ± standard error of the mean, unless otherwise indicated. Data sets were examined with one- or two-way analysis of variance, and individual group means were then compared by Student's t-test.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Using fixation (expressed as the binding index) to lung of
125I-labeled monoclonal antibody to P-selectin, significant
upregulation of P-selectin was found at 2 hours
(P = 0.002), persisting at 3 hours
(P = 0.001) and 4 hours
(P = 0.007) after initiation of lung
inflammatory reactions (Figure 1A)
. By 4
hours, the binding index had risen by 2.6-fold when compared with the
value obtained at time 0. No significant increase in binding of
125I-labeled MOPC was observed at any of the time points
studied (Figure 1A)
. For the sake of comparison, upregulation of
P-selectin was also evaluated in the model of acute lung injury
occurring after systemic activation of complement. As expected,
significant upregulation of P-selectin was found 30 minutes after
infusion of CVF, as shown in Figure 1B
. The index for
125I-labeled anti-P-selectin was 0.63 ± 0.08,
approximately 3.5-fold above the level found at time 0
(P = 0.003). No significant increase in bound
125I-labeled MOPC was observed at the two intervals of
time. At 60 minutes after infusion of CVF, there was no difference
between the lung binding of MOPC-21 and anti-P-selectin (Figure 1B)
. It
has been recently shown that upregulation of P-selectin in the CVF
model is C5a dependent and essential for neutrophil accumulation in
lung and attendant full expression of lung injury, even though
upregulation of P-selectin under these circumstances is very transient,
disappearing within 30 minutes.9,10
Thus, in the two models
of injury, expression of P-selectin is transient in one and prolonged
in the other.
|
The presence of P-selectin in homogenates of whole lung during
intrapulmonary deposition of IgG immune complexes was determined using
a Western blot technique. There was little, if any, detectable
P-selectin in lung homogenates at time 0 (Figure 2)
. However, P-selectin was readily
detectable in homogenates of lung by 1 hour after initiation of the
lung inflammatory reactions, persisting at 2, 4, 6, and 8 hours (Figure 2)
.
|
Lungs of rats undergoing IgG immune complex deposition were
evaluated by immunostaining techniques at 0, 1, 2, and 4 hours after
initiation of the reaction. At time 0, no staining for P-selectin was
detectable in the lung vasculature (Figure 3A)
. However, by 1 hour (Figure 3B)
,
products of immunostaining were visible along venular surfaces (Figure 3B
, arrow) and in the interstitium in what appeared to be interstitial
capillaries. At the 2- and 4-hour intervals (Figure 3, C and D)
, there
was evidence of immunostaining for P-selectin in a similar
distribution.
|
In this series of studies employing the IgG immune complex-induced
injury of lung, we sought to determine whether neutrophils, oxidants,
complement C5a, and TNF- were required for the upregulation of lung
vascular P-selectin, using the binding index for P-selectin as the
endpoint. In turn, these findings were compared with those in the lung
model of injury after systemic activation of complement. Upregulation
of lung vascular P-selectin was measured by binding of
125I-labeled ARP2-4. Intraperitoneal injection of the
antioxidant DMSO is known to be effective in reducing neutrophil- and
oxidant-mediated injury in both models of lung
injury.16,17,26
In the IgG immune complex model of lung
injury, treatment of rats with DMSO reduced P-selectin upregulation by
62% (P = 0.005), whereas neutrophil depletion
reduced this upregulation by 47% (P = 0.045)
(Figure 4A)
. Companion experiments were
done using the model of systemic activation of complement after
intravenous infusion of CVF. In this model, it has recently been shown
that upregulation of lung vascular P-selectin can be greatly attenuated
in rats that are complement depleted or treated with
anti-C5a.10,27
In the current studies and similar to
findings in the immune complex model, treatment with DMSO reduced lung
vascular upregulation of P-selectin by 75% (P =
0.003) (Figure 4B)
, whereas neutrophil depletion failed to affect
upregulation of P-selectin after intravenous infusion of CVF (Figure 4C)
. Thus, in these two models of lung injury, upregulation of
P-selectin shows a strikingly different time course and appears to be
oxidant mediated, but the source of the oxidants may be different,
based on the differing effects of neutrophil depletion.
|
have been shown to play key
roles in neutrophil recruitment and full development of lung injury in
the IgG immune complex-induced model of lung injury, being ultimately
linked to upregulation of lung vascular ICAM-1 and
E-selectin.1-3,7
We assessed to what extent upregulation
of lung vascular P-selectin, 4 hours after intrapulmonary deposition of
IgG immune complexes, would be affected by complement depletion or by
treatment with anti-C5a or anti-TNF-. The results of these studies
are shown in Figure 5
. In rats depleted
of complement, upregulation of lung vascular P-selectin was decreased
by 67% (P = 0.0003). Intratracheal instillation
of 400 µg of anti-rat C5a IgG reduced upregulation of P-selectin by
43% (P = 0.001) when compared with the effects
of similar treatment with 400 µg of preimmune IgG (Figure 5B)
. In
contrast, treatment of rats with anti-TNF- failed to affect
upregulation of P-selectin (Figure 5A)
, although the same treatment
caused a pronounced reduction in upregulation of lung vascular ICAM-1,
in neutrophil recruitment, and in the degree of lung
injury.2,3
Accordingly, it is clear that upregulation of
P-selectin and ICAM-1 in the immune complex model of lung injury occurs
via different mechanisms.
|
Expression of mRNA for TNF- and P-selectin in lungs was
investigated by Northern blot analysis of lung homogenates obtained at
various time points in animals undergoing IgG immune complex-induced
lung injury. The expression of mRNA for P-selectin was preceded by
expression of mRNA for TNF-. As shown in Figure 6
(middle frame), mRNA for TNF- was
first detected as early as 0.5 hours after the induction of injury,
with a peak at 2 hours, followed by a decline thereafter. In contrast,
mRNA for P-selectin could only be found at 4 hours (considerably after
detectable P-selectin protein in lung homogenates), with disappearance
thereafter (Figure 6
, top frame). Rehybridization of the membrane with
a ß-actin mRNA probe as an internal control confirmed that
approximately equal quantities of mRNA samples had been loaded into
each lane (Figure 6
, bottom frame).
|
The following experiments indicate that the appearance of
P-selectin in lung after deposition of IgG immune complexes is
important for neutrophil recruitment and full development of lung
injury (Figure 7)
. The intravenous
infusion of 400 µg of mouse monoclonal anti-rat P-selectin (ARP2-4)
at the onset of the injury (time 0) was associated with significantly
protective effects after IgG immune complex deposition. The vascular
permeability index, which rose nearly fivefold in the positive control
group when compared with the negative control group, decreased by 43%
(falling to a value of 0.63 ± 0.05, P = 0.003) in
animals treated with anti-P-selectin when compared with positive
control animals without further treatment or positive control animals
treated intravenously with 400 µg of MOPC-21 (Figure 7A)
. BAL fluids
were evaluated for neutrophil content in the negative control group, in
the positive control groups otherwise untreated (Figure 7A
, "none"
columns), and in the positive control group infused intravenously at
time 0 with 400 µg of MOPC-21 or ARP2-4. The results are shown in
Figure 7B
. Neutrophil content (x 106)in BAL fluids rose
from 0.37 ± 0.06 in the negative control group to 1.94 ±
0.39 in the positive control groups not otherwise treated
(P < 0.001) and to 2.14 ± 0.50 in the
positive control group treated with 400 µg of MOPC-21
(P < 0.001). In positive control animals
treated intravenously with 400 µg of ARP2-4, there was a 74%
decrease (P = 0.013) in numbers of BAL
neutrophils falling to 0.77 ± 0.12 neutrophils (x
106)/ml (Figure 7B)
. Thus, blockade of P-selectin
dramatically reduces recruitment of neutrophils into the lung and
protects against the full development of lung injury.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
or
interleukin-1, with protein expression peaking at 4 hours and returning
to background levels by 16 to 24 hours. Constitutive P-selectin is
stored in Weibel-Palade bodies of endothelial cells and is transported
to the cell surface within minutes on stimulation of endothelial
cells.34,35
Histamine-induced upregulation of P-selectin in
endothelial cells in vitro is transient, peaking at 10 to 15
minutes and then rapidly disappearing, presumably because of endocytic
removal of P-selectin. Upregulation of P-selectin on endothelial cells
also occurs after contact with H202, but in
this case P-selectin upregulation is stably expressed, lasting several
hours,36
perhaps because H202 has
damaged the endocytic apparatus, resulting in prolonged surface
expression of P-selectin. It is also known that, under certain
conditions, transcriptional upregulation of P-selectin can occur
in vivo.37-39 Both P-selectin and L-selectin seem to play a role in lipopolysaccharide-induced leukocyte rolling in the rat mesentery, but only P-selectin seems to be required for lipopolysaccharide-induced firm leukocyte adhesion to the endothelium.39 In the lung injury model after systemic activation of complement by CVF, very early and transient (15 to 20 minutes) upregulation of P-selectin in the lung vasculature occurs, followed by rapid down-regulation.9 This pattern mimics the well known transient pattern of in vitro expression (10 to 15 minutes) of P-selectin in human umbilical vein endothelial cells stimulated by histamine, thrombin, H202, or C5a.35,36,40 In the CVF model of lung injury, in vivo upregulation of P-selectin is blocked in the presence of anti-C5a. In the CVF model of lung injury, the requirement for P-selectin for full development of lung injury has been documented by the protective effects of anti-P-selectin or human P-selectin-Ig.8,9 In earlier studies involving the IgG immune complex model of lung injury, it was concluded that P-selectin was not involved because of the failure of P-selectin-Ig to protect against neutrophil accumulation and full development of lung injury.8 However, the current studies clearly show upregulation of P-selectin (by Western blot analysis, by in vivo fixation of 125I-labeled antibody, and by immunostaining). The use of monoclonal antibody to rat P-selectin also revealed protective effects in vivo. In this model, the very early but persistent appearance of P-selectin (as determined by immunostaining, tissue fixation of 125I-labeled anti-P-selectin, and Western blot analysis) long before the appearance of P-selectin mRNA suggests that the source of P-selectin may be constitutive.
As emphasized above, the onset of upregulation of P-selectin and its
transient or persistent nature in rat lung are shown in striking
contrast in the two lung models used (Figure 8)
. In the case of intrapulmonary
deposition of IgG immune complexes, C5a, which is generated in the
vicinity of the immune complex deposits,27
may lead to
activation of intravascular neutrophils, which then become more rigid
(less deformable) and entrapped within the pulmonary microvasculature.
Under these conditions, activated neutrophils could deliver significant
amounts of H202 to adjacent endothelial cells,
causing persistent upregulation of P-selectin on endothelial cell
surfaces. This might be analogous to the well described in
vitro exposure of human umbilical vein endothelial cells to
H202, which results in sustained surface
expression of P-selectin.36
The appearance of P-selectin,
together with TNF--induced upregulation of ICAM-1 and
E-selectin,41
may set the stage for neutrophil adhesion to
lung vascular endothelial cells and subsequent migration into the
interstitial and alveolar compartments. It should be pointed out that,
although neutrophils activated by intravascular infusion of formyl
met-leu-phe or zymosan-activated plasma accumulate within the lung
vasculature, this does not lead to injury nor does it lead to
transmigration of neutrophils.42,43
Clearly, activation of
neutrophils is not sufficient to injure the lung vasculature.
Endothelial adhesion molecules are also required to facilitate events
that lead to injury of lung endothelial and alveolar epithelial cells.
|
. This event
is crucial in promoting intimate adhesive contacts between
C5a-activated blood neutrophils and the activated endothelium. Blockade
of P-selectin or C5a in this model by the use of antibody interferes
with adhesive interactions between neutrophils and endothelial cells,
resulting in diminished accumulation of neutrophils and reduced
intensity of lung damage.10
This transient expression of
endothelial P-selectin would be similar to what has been found in
vitro with C5a-stimulated endothelial cells, as described above.
These events are in sharp contrast to the pattern of upregulation of
lung vascular P-selectin after intrapulmonary deposition of IgG immune
complexes. In this case, the appearance of P-selectin is delayed, only
being measurable after the first 60 minutes. However, P-selectin
expression is persistent for up to the 8-hour interval.
The two different pathways of P-selectin expression may be related to
why the first is neutrophil dependent whereas the second is neutrophil
independent. In both cases the presence of DMSO suggests that oxidants
delivered to or generated within endothelial cells are required for
P-selectin expression. DMSO is known to be a scavenger for the hydroxyl
radical,18-21
which could suggest that neutrophil-derived
H202 and/or endothelial cell-derived superoxide
are ultimately converted to the hydroxyl radical (HO·), which causes
upregulation of P-selectin, although there is no direct proof for such
a conclusion. There is evidence that in vitro expression of
P-selectin by endothelial cells is dependent on nuclear factor 
B
activation and requires participation of intracellular oxidants, as
assessed by the inhibitory effects of N-acetylcysteine or
pyrrolidine dithiocarbamate.44
However, the precise
source and the role of endothelial intracellular oxidants await
definition. In the immune complex model of lung injury, the requirement
of neutrophils for upregulation of P-selectin may be due to the
delivery to endothelial cells of H202 generated
by the large number of neutrophils accumulating in the interstitial and
alveolar compartments. The combination of C5a together with immune
complexes would represent a powerful stimulus for neutrophil activation
in the lung. The diffusion of H202 into nearby
endothelial cells may, as in the in vitro situation in
which addition of H202 leads to sustained
expression of endothelial P-selectin, lead to long-lasting expression
of P-selectin on vascular endothelial surfaces of lung.
The data in this report suggest that in the IgG immune complex model of lung injury, P-selectin plays an important role in events that contribute to the recruitment of neutrophils into the lung. The prior attempts to define the role of P-selectin in this model of injury, using P-selectin-Ig (which would compete with endogenous P-selectin), failed to suggest a role for P-selectin.8 However, a single infusion of P-selectin-Ig at time 0 may have been insufficient to saturate binding sites on neutrophils, namely, P-selectin glycoprotein ligand-1. The ability of antibody to rat P-selectin to reduce injury in the IgG immune complex model of lung injury, together with the clear evidence for the sustained appearance of P-selectin in lung during development of the inflammatory response, documents a role for P-selectin in this model of lung injury. It is also clear that the appearance of P-selectin protein occurs hours before mRNA expression can be detected in lung. It seems likely that endogenous endothelial P-selectin is the source for P-selectin in this model of lung injury, the source(s) of constitutive P-selectin being described above.
The sources of P-selectin in the IgG immune complex model of injury would most likely be endothelial cells (Weibel-Palade granules) or platelets. The late appearance of mRNA for P-selectin (at 4 hours) suggests that expression of P-selectin in lung as early as 1 hour is likely to involve constitutive rather than inducible P-selectin. The immunostaining pattern suggests that endothelial cells may be the source, although we cannot rule out that platelets adherent to the endothelium could account for this finding. In this model, we have found no evidence of platelet adhesion to the endothelium on the basis of transmission electron microscopy (P. A. Ward, unpublished observations). Platelet depletion experiments have been used to address the issue of the source of P-selectin. However, because injury induced by intrapulmonary deposition of IgG immune complexes is inherently hemorrhagic, under conditions of platelet depletion the outcome in the lung is extensive intrapulmonary hemorrhage, which makes platelet depletion procedures unusable (N. M. Bless and P.A. Ward, unpublished observations).
In the immune complex model of lung injury, the ultimate pathway leading to endothelial injury appears to involve the conversion of neutrophil-derived H202 within endothelial cells to HO· in the presence of Fe2+.45 In the CVF model in which large amounts of C5a are generated,46 there may be early and intense but transient expression of P-selectin on endothelial surfaces, sufficient to facilitate selectin-dependent adhesive interactions, followed by ß2 integrin-dependent and ICAM-1-dependent adhesive interactions. Details regarding the different patterns of lung vascular expression of P-selectin remain to be defined.
|
Acknowledgements |
|---|
DNA probe.
The authors also thank Ms. Beverly Schumann and Ms. Peggy Otto for
their assistance in the preparation of the manuscript. |
Footnotes |
|---|
Supported by National Institutes of Health grants HL-31963 and AI-33189.
Accepted for publication June 8, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 1995, 142:1739-1749[Abstract]
-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989, 84:92-99
regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 1993, 142:1739-1749
B) activation. Am J Pathol 1997, 150:2019-2031[Abstract]
This article has been cited by other articles:
 |
|
 |
|
  N. Miyao, Y. Suzuki, K. Takeshita, H. Kudo, M. Ishii, R. Hiraoka, K. Nishio, T. Tamatani, S. Sakamoto, M. Suematsu, et al. Various adhesion molecules impair microvascular leukocyte kinetics in ventilator-induced lung injury Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1059 - L1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Vlasenko and A. J. Melendez A Critical Role for Sphingosine Kinase in Anaphylatoxin-Induced Neutropenia, Peritonitis, and Cytokine Production in Vivo J. Immunol., May 15, 2005; 174(10): 6456 - 6461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. B. M. Ibrahim, S. J. Pang, and A. J. Melendez Anaphylatoxin Signaling in Human Neutrophils: A KEY ROLE FOR SPHINGOSINE KINASE J. Biol. Chem., October 22, 2004; 279(43): 44802 - 44811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Melendez and F. B. M. Ibrahim Antisense Knockdown of Sphingosine Kinase 1 in Human Macrophages Inhibits C5a Receptor-Dependent Signal Transduction, Ca2+ Signals, Enzyme Release, Cytokine Production, and Chemotaxis J. Immunol., August 1, 2004; 173(3): 1596 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Albrecht, A. M. Chinnaiyan, S. Varambally, C. Kumar-Sinha, T. R. Barrette, J. V. Sarma, and P. A. Ward C5a-Induced Gene Expression in Human Umbilical Vein Endothelial Cells Am. J. Pathol., March 1, 2004; 164(3): 849 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Serrano-Mollar, D Closa, J Cortijo, E J Morcillo, N Prats, M Gironella, J Panes, J Rosello-Catafau, and O Bulbena P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine Thorax, July 1, 2002; 57(7): 629 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hayashi, Y. Sawa, N. Fukuyama, H. Nakazawa, and H. Matsuda Inducible nitric oxide production is an adaptation to cardiopulmonary bypass-induced inflammatory response Ann. Thorac. Surg., July 1, 2001; 72(1): 149 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hayashi, Y. Sawa, M. Nishimura, S. J. Tojo, N. Fukuyama, H. Nakazawa, and H. Matsuda P-selectin participates in cardiopulmonary bypass-induced inflammatory response in association with nitric oxide and peroxynitrite production J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 558 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Strachan, T. M. Woodruff, G. Haaima, D. P. Fairlie, and S. M. Taylor A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats J. Immunol., June 15, 2000; 164(12): 6560 - 6565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Mulligan, R. L. Warner, C. W. Rittershaus, L. J. Thomas, U. S. Ryan, K. E. Foreman, L. D. Crouch, G. O. Till, and P. A. Ward Endothelial Targeting and Enhanced Antiinflammatory Effects of Complement Inhibitors Possessing Sialyl Lewisx Moieties J. Immunol., April 15, 1999; 162(8): 4952 - 4959. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
4.
